Albert Kheradpour

475 total citations
18 papers, 247 citations indexed

About

Albert Kheradpour is a scholar working on Oncology, Dermatology and Epidemiology. According to data from OpenAlex, Albert Kheradpour has authored 18 papers receiving a total of 247 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Dermatology and 5 papers in Epidemiology. Recurrent topics in Albert Kheradpour's work include Cutaneous lymphoproliferative disorders research (5 papers), CAR-T cell therapy research (4 papers) and Acute Lymphoblastic Leukemia research (4 papers). Albert Kheradpour is often cited by papers focused on Cutaneous lymphoproliferative disorders research (5 papers), CAR-T cell therapy research (4 papers) and Acute Lymphoblastic Leukemia research (4 papers). Albert Kheradpour collaborates with scholars based in United States, Italy and South Korea. Albert Kheradpour's co-authors include Erdem Göker, Y Elisseyeff, Mark Waltham, Ellin Berman, Tanya Trippett, Madhu Mazumdar, Peter G. Steinherz, Barbara Schnieders, Joseph R. Bertino and W P Tong and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Albert Kheradpour

17 papers receiving 242 citations

Peers

Albert Kheradpour

PHEOH

HEMAT

ONCOL

RHEUM

Huyong Zheng China

Mutlu Kartal‐Kaess Germany

Rossana Putzulu Italy

Shaoyan Hu China

Min‐Yuan Wu China

AC Homans United States

Shotaro Iwamoto Japan

Rupa Narayan United States

Etsuko Aoki United States

Patrizia Scaravaglio Italy

Huyong Zheng China

Albert Kheradpour

144 ×1.5

163 ×1.8

PHEOH

111 ×1.5

HEMAT

59 ×1.0

ONCOL

15 ×0.5

RHEUM

Citations per year, relative to Albert Kheradpour Albert Kheradpour (= 1×) peers Huyong Zheng

Countries citing papers authored by Albert Kheradpour

Since Specialization

Citations

This map shows the geographic impact of Albert Kheradpour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Kheradpour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Kheradpour more than expected).

Fields of papers citing papers by Albert Kheradpour

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Kheradpour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Kheradpour. The network helps show where Albert Kheradpour may publish in the future.

Co-authorship network of co-authors of Albert Kheradpour

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Kheradpour. A scholar is included among the top collaborators of Albert Kheradpour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Kheradpour. Albert Kheradpour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Xu, Dan, et al.. (2025). Anemia Due to Unexpected Zinc-Induced Copper Deficiency. Hematology Reports. 17(4). 35–35.

Pemmaraju, Naveen, Branko Cuglievan, Joseph A. Lasky, et al.. (2024). Efficacy and manageable safety of tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a case series of pediatric and adolescent/young adult patients. SHILAP Revista de lepidopterología. 5(1). 61–69. 4 indexed citations

Pemmaraju, Naveen, Branko Cuglievan, Joseph A. Lasky, et al.. (2022). AML-392 Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm in Pediatric Patients With Tagraxofusp, a CD123-Targeted Therapy. Clinical Lymphoma Myeloma & Leukemia. 22. S244–S245. 1 indexed citations

Pemmaraju, Naveen, Branko Cuglievan, Joseph L. Lasky, et al.. (2022). P521: TREATMENT OF BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM IN PEDIATRIC PATIENTS WITH TAGRAXOFUSP, A CD123-TARGETED THERAPY. HemaSphere. 6. 420–421. 1 indexed citations

Pemmaraju, Naveen, Branko Cuglievan, Joseph L. Lasky, et al.. (2021). Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in Pediatric Patients with Tagraxofusp, a CD123-Targeted Therapy. Blood. 138(Supplement 1). 2317–2317. 3 indexed citations

Gospodarev, Vadim, et al.. (2019). Benign Giant Cell Lesion of C1 Lateral Mass: A Case Report and Literature Review. Brain Sciences. 9(5). 105–105. 3 indexed citations

Xue, Lijun, Craig W. Zuppan, Tiannan Wang, et al.. (2019). Plasma Cell Myeloma Type Posttransplant Lymphoproliferative Disorder in an 18-Month-Old Heart Transplant Recipient: Case Report and Review of the Literature. Journal of Pediatric Hematology/Oncology. 42(3). e170–e173. 1 indexed citations

Mahajan, Priya, Albert Kheradpour, Norma Quintanilla, et al.. (2018). Response to Lenvatinib in Children with Papillary Thyroid Carcinoma. Thyroid. 28(11). 1450–1454. 19 indexed citations

Li, Lei, et al.. (2018). Spontaneous Regression of Diffuse Periosteal Melanotic Neuroectodermal Tumor of Infancy in the Tibia, With 13-Year Follow-up. Journal of Pediatric Hematology/Oncology. 41(2). 148–151. 1 indexed citations

10.

Zhang, Huina, Albert Kheradpour, Edward H. Rowsell, et al.. (2015). Cytotoxic Molecule–positive Epstein-Barr Virus–associated Peripheral T-cell Lymphoma in a 20-Month-old Child. Journal of Pediatric Hematology/Oncology. 37(8). e475–e480. 1 indexed citations

11.

Kheradpour, Albert, et al.. (2013). Mast Cell Sarcoma in an Infant. Journal of Pediatric Hematology/Oncology. 35(4). 315–320. 14 indexed citations

12.

Yang, Rui, Weiwei Li, Bang H. Hoang, et al.. (2008). Quantitative correlation between promoter methylation and messenger RNA levels of the reduced folate carrier. BMC Cancer. 8(1). 124–124. 23 indexed citations

13.

Plonczynski, Maria W., et al.. (1998). Severe Hb S-β⁺Thalassemia Caused by IVS-I Splice Site Mutations. Hemoglobin. 22(4). 383–386. 1 indexed citations

14.

Kheradpour, Albert, Ellin Berman, Erdem Göker, et al.. (1995). A Phase II Study of Continuous Infusion of Trimetrexate in Patients with Refractory Acute Leukemia. Cancer Investigation. 13(1). 36–40. 10 indexed citations

15.

Göker, Erdem, Mark Waltham, Albert Kheradpour, et al.. (1995). Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia and is correlated with p53 gene mutations. Blood. 86(2). 677–684. 109 indexed citations

16.

Göker, Erdem, Albert Kheradpour, Mark Waltham, et al.. (1995). Acute monocytic leukemia: a myeloid leukemia subset that may be sensitive to methotrexate.. PubMed. 9(2). 274–6. 21 indexed citations

17.

Lacerda, João F., Erdem Göker, Albert Kheradpour, et al.. (1995). Selective treatment of SCID mice bearing methotrexate-transport- resistant human acute lymphoblastic leukemia tumors with trimetrexate and leucovorin protection. Blood. 85(10). 2675–2679. 24 indexed citations

18.

Tan, Chee-Seng, Norma Wollner, Tanya Trippett, et al.. (1994). Pharmacologic-guided trial of sequential methotrexate and thioguanine in children with advanced malignancies.. Journal of Clinical Oncology. 12(9). 1955–1962. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact